These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic Melanoma. Reddy SB; Possick JD; Kluger HM; Galan A; Han D J Immunother; 2017 Oct; 40(8):307-311. PubMed ID: 28737620 [TBL] [Abstract][Full Text] [Related]
13. Sarcoidosis post-anti-PD-1 therapy, mimicking relapse of metastatic melanoma in a patient undergoing complete remission. Yatim N; Mateus C; Charles P Rev Med Interne; 2018 Feb; 39(2):130-133. PubMed ID: 29277453 [TBL] [Abstract][Full Text] [Related]
14. Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update. Kähler KC; Hassel JC; Heinzerling L; Loquai C; Thoms KM; Ugurel S; Zimmer L; Gutzmer R; J Dtsch Dermatol Ges; 2020 Jun; 18(6):582-609. PubMed ID: 32489011 [TBL] [Abstract][Full Text] [Related]
15. Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis. Lomax AJ; McGuire HM; McNeil C; Choi CJ; Hersey P; Karikios D; Shannon K; van Hal S; Carr U; Crotty A; Gupta SK; Hollingsworth J; Kim H; Fazekas de St Groth B; McGill N Int J Rheum Dis; 2017 Sep; 20(9):1277-1285. PubMed ID: 28480561 [TBL] [Abstract][Full Text] [Related]
16. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma. Mahoney KM; Freeman GJ; McDermott DF Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918 [TBL] [Abstract][Full Text] [Related]
17. A new frontier in treatment of advanced melanoma: Redefining clinical management in the era of immune checkpoint inhibitors. Levine O; Devji T; Xie F Hum Vaccin Immunother; 2017 Aug; 13(8):1765-1767. PubMed ID: 28481695 [TBL] [Abstract][Full Text] [Related]
19. Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy. La-Beck NM; Jean GW; Huynh C; Alzghari SK; Lowe DB Pharmacotherapy; 2015 Oct; 35(10):963-76. PubMed ID: 26497482 [TBL] [Abstract][Full Text] [Related]